Tiglutik
Active Ingredient(s): RiluzoleFDA Approved: * September 5, 2018
Pharm Company: * ITALFARMACO SPA
Category: Neurological Disorders
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Tiglutik Overview
Riluzole is a medication used to treat amyotrophic lateral sclerosis. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months.[2] Riluzole is available in tablet and liquid form. Contents 1 Medical use 1.1 Amyotrophic lateral sclerosis 2 Adverse effects 2.1 Overdose 3 Contraindications 3.1 Interactions 4 Mechanism of action 5 Synthesis 6 Society and culture 6.1 Legal status 7 Research 8 Se...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Riluzole
Recent Tiglutik Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Riluzole
- Film: 50mg
- Suspension: 50mg/10ml
- Tablet: 50mg
Other drugs which contain Riluzole or a similar ingredient: (3 results)
- EXSERVAN Riluzole
- RILUTEK Riluzole1 discussion
- RILUZOLE 1 discussion